Press Release: Avalyn Pharma : Avalyn to Participate in Multiple Upcoming Investor Conferences in November
BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on the development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced that management will participate in the following upcoming investor conferences in November.
Read full article »
Avalyn is a Washington-based biopharmaceutical company that researches and develops novel therapies for the treatment of respiratory diseases.
Read more